Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Acyclovir for Molluscum Contagiosum in Children
NCT04476186Unknown
- Start
- Jun 2020
- Primary completion
- Dec 2021
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Randomised, open-label trial of aciclovir in molluscum contagiosum (MC) (2 arms). Primary endpoint: Percentage of patient with complete clearance of all molluscum lesions at 3 months. Status: unknown.
02
Drugs
aciclovir
03
Conditions
molluscum contagiosum (MC)
Beyond the preview
Go deeper on NCT04476186.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04476186.